Security
Instinct Bio Technical Company Holdings Inc. · BIOT
BIOTNASDAQCommon stockCurrentCIK 2072188Updated Oct 6, 2026
BIOT price & chart
Loading TradingView…
NASDAQ:BIOT on TradingView ↗About the company
INC. INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) is a diversified healthcare and biotechnology company focused on developing and expanding businesses across beauty, wellness, regenerative medicine and related healthcare sectors. Through its operations and strategic partnerships, BIOT seeks to build an integrated platform connecting innovative healthcare technologies, products and services with growth opportunities across Asia and other international markets. For more information, please visit https://instinct-biot.com/
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Filing attachments
tm2626707d1_ex99-1.htm · 6-K · 2026-10-01
Exhibit 99.1 BIOT Named Authorized Representative for IN01 Cancer Immunotherapy in Japan and China Non-exclusive appointment by CelSiege Biosciences extends BIOT's business development activities into clinical-stage oncology NEW YORK and TOKYO, September 30, 2026 - INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) ("BIOT" or the "Company") today announced that CelSiege Biosciences Inc. ("CelSiege") has appointed BIOT, on a non-exclusive basis, as its authorized introduction and bu…
Read attachment ↗tm2625442d1_ex99-1.htm · 6-K · 2026-09-15
Exhibit 99.1 Instinct Bio Receives Nasdaq Notifications Regarding Minimum Bid Requirement and Minimum Market Value of Listed Securities and Publicly Held Shares NEW YORK and TOKYO, September 15, 2026 - Instinct Bio Technical Company Holdings Inc. (Nasdaq Symbols: BIOT, BIOTW) (“Instinct Bio” or the “Company”) today announced that on September 9, 2026 and September 10, 2026 it received notifications from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), as describ…
Read attachment ↗tm2624858d1_ex99-1.htm · 6-K · 2026-09-08
Exhibit 99.1 INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives Follow-up to the Company’s July 29, July 30 and August 10, 2026 announcements NEW YORK and TOKYO, September 4, 2026 (GLOBE NEWSWIRE) - INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) (“Instinct Bio” or the “Company”) today provided an operational update on the initiatives previously announced on July 29, July 30 and August 10, 2026, relating to its GENRÊVER CLINIC…
Read attachment ↗tm2622710d1_ex99-1.htm · 6-K · 2026-08-10
Exhibit 99.1 Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia NEW YORK, NY and TOKYO, JAPAN - August 10, 2026 - INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) (“Instinct Bio” or the “Company”) today announced a cooperation agreement with PT PARVA CANDELA ("PARVA"), an Indonesian cosmetics manufacturer and distributor, to jointly develop Indonesia’s cosmetics and personal care market under a "Made in Indonesia, Powered …
Read attachment ↗tm2621810d1_ex99-1.htm · 6-K · 2026-07-31
Exhibit 99.1 Instinct Bio Announces Strategic Collaboration with INVITRX to Expand GENRÊVER into U.S. and Advance Indonesia Regenerative Medicine Initiatives Collaboration combines Japanese product innovation, U.S. GMP manufacturing capabilities and regenerative medicine expertise to support the next phase of Instinct Bio's international growth NEW YORK, NY and TOKYO, JAPAN - July 30, 2026 - INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) ("Instinct Bio" or the "Company") today an…
Read attachment ↗tm2621671d1_ex99-1.htm · 6-K · 2026-07-30
Exhibit 99.1 BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” - Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets First wave of five directly operated clinics across Indonesia’s five major metropolitan areas with an initial investment of approximately US$1 million; standardized, machine-led clinic format designed for disciplined, self-funded expansion; positioned as a strategic gateway to t…
Read attachment ↗